Aortic valve replacement (AVR) significantly reduced all-cause mortality by 57% compared to conservative management in asymptomatic aortic stenosis patients (IRR = 0.43).
Does transcatheter or surgical aortic valve replacement reduce mortality in patients with asymptomatic severe aortic stenosis compared to conservative management?
Aortic valve replacement (TAVR or SAVR) is associated with significantly lower short- and long-term mortality compared to conservative management in patients with asymptomatic severe aortic stenosis.
Absolute Event Rate: 0% vs 0%
Abstract OBJECTIVES The management of asymptomatic aortic stenosis (AS) is controversial. We perform a meta-analysis of reconstructed individual patient data to compare conservative treatment versus transcatheter or surgical aortic valve replacement (TAVR or SAVR) in asymptomatic AS. METHODS PubMed/MEDLINE, Web of Science, Scopus, and Cochrane CENTRAL were systematically searched, through 25th September 2025, to identify any observational or randomized controlled studies that comply with our inclusion criteria. Our primary outcomes were short cardiovascular and non-cardiovascular mortality as well as long-term mortality. We combined aggregate data meta-analysis for dichotomous outcomes using incidence rate ratio (IRR) with reconstructed time-to-event data derived from published Kaplan–Meier curves using validated algorithms. RESULTS Seventeen studies were included. Overall, AVR was associated with a significantly lower risk of all-cause mortality compared with conservative management (IRR = 0.43; 95% CI, 0.32–0.57; p 0.001). Cardiovascular mortality was also significantly reduced with AVR (IRR = 0.47; 95% CI, 0.29–0.75; p 0.01; I2 = 62%). The risk of heart failure hospitalization was markedly lower among AVR recipients (IRR = 0.39; 95% CI, 0.22–0.67; p 0.01), with consistent benefit across study designs. AVR was further associated with a substantial reduction in sudden cardiac death (IRR = 0.13; 95% CI, 0.04–0.48; p 0.01) and myocardial infarction (IRR = 0.11; 95% CI, 0.04–0.31; p = 0.03). The risk of stroke was not significantly different between groups (IRR = 0.77; 95% CI, 0.58–1.02; p = 0.07). Reconstructed Kaplan–Meier analyses demonstrated durable long-term survival benefit with AVR, consistent across surgical and transcatheter approaches CONCLUSIONS Patients with asymptomatic AS, managed with either SAVR or TAVR, were associated with lower short- and long-term mortality compared to conservative management.
Awad et al. (Tue,) reported a other. Aortic valve replacement (AVR) significantly reduced all-cause mortality by 57% compared to conservative management in asymptomatic aortic stenosis patients (IRR = 0.43).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: